GO:0050680 negative regulation of epithelial cell proliferation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050680 describes any biological process that stops, prevents, or reduces the rate or extent of epithelial cell proliferation.
• It is essential for tissue homeostasis, wound repair, and preventing fibrotic or malignant expansion of epithelial compartments.
• Key negative regulators include KLF4, T-cell protein tyrosine phosphatase (PTPN2), Id-1, and mTORC1-dependent signaling.
• Loss of negative regulation leads to hyperproliferation in diseases such as glomerular disease, colorectal cancer, and fibrosis.
• CRISPR knockout, point mutation, and overexpression models are powerful tools to dissect causal roles of candidate genes in this process.
• Studying this term requires combining transcriptomics, proteomics, imaging, and functional proliferation assays.
Description
Epithelial tissues line the surfaces and cavities of the body and rely on a precise balance between cell division and growth arrest to maintain normal function. The Gene Ontology term GO:0050680, negative regulation of epithelial cell proliferation, captures the biological processes that stop, prevent, or reduce the rate or extent of epithelial cell proliferation. This term is fundamental for understanding how tissues avoid uncontrolled expansion and how disruptions contribute to diseases such as cancer, fibrosis, and chronic inflammatory conditions. Researchers study this process to identify molecular brakes on epithelial growth, to understand tissue homeostasis, and to develop targeted therapies that restore proliferative control.
negative regulation of epithelial cell proliferation At A Glance
| GO ID | GO:0050680 |
|---|---|
| GO term | negative regulation of epithelial cell proliferation |
| Ontology | biological_process |
| Synonym | down regulation of epithelial cell proliferation, down-regulation of epithelial cell proliferation, downregulation of epithelial cell proliferation, inhibition of epithelial cell proliferation |
| Major function | Stops, prevents, or reduces the rate or extent of epithelial cell proliferation |
| Related processes | Cell cycle arrest, differentiation, apoptosis, tissue homeostasis |
| Key regulators | KLF4, PTPN2, Id-1, mTORC1, STAT3 |
| Disease relevance | Cancer, fibrosis, glomerular disease, inflammatory disorders |
What Is GO:0050680?
GO:0050680 refers to any process that stops, prevents, or reduces the rate or extent of epithelial cell proliferation. It encompasses signaling events, transcriptional programs, and cell-cycle checkpoints that limit the division of epithelial cells, ensuring proper tissue architecture and preventing pathological overgrowth.
Why Is negative regulation of epithelial cell proliferation Important in Cell Biology?
Negative regulation of epithelial cell proliferation is critical for maintaining tissue homeostasis and preventing diseases characterized by uncontrolled epithelial growth. Dysregulation of this process is a hallmark of cancer, fibrosis, and chronic inflammatory diseases, making it a key area for therapeutic intervention.
• Prevents uncontrolled epithelial expansion that can lead to tumor formation.
• Maintains tissue architecture and organ function by balancing proliferation and differentiation.
• Plays a role in wound healing by terminating proliferative phases.
• Dysregulation contributes to fibrotic maladaptive repair in organs such as kidney and lung.
• Loss of negative regulators like KLF4 is linked to glomerular disease.
• mTORC1 signaling is essential for colonic epithelial homeostasis and its dysregulation causes hyperplasia.
• Id-1 overexpression alters mammary epithelial phenotypes, highlighting its role in proliferation control.
• PTPN2 acts as a tumor suppressor in epithelial carcinogenesis.
• Understanding this process aids in developing targeted therapies for epithelial cancers.
• CRISPR-based models enable precise dissection of causal genes in this pathway.
What Happens During negative regulation of epithelial cell proliferation?
Initiation of negative signals
In simple terms: Cells receive stop signals that tell them not to divide.
Negative regulation begins when epithelial cells receive extracellular or intracellular cues that activate growth-inhibitory pathways. For example, KLF4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation, acting as a brake on proliferative signaling. Similarly, T-cell protein tyrosine phosphatase (PTPN2) can dephosphorylate growth factor receptors and downstream kinases to dampen proliferative signals.
Cell cycle arrest
In simple terms: The cell cycle machinery is halted, preventing cells from progressing to division.
Once negative signals are integrated, key cell cycle checkpoints are activated. circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair, indicating that G2-M transition is a critical node for negative regulation. mTORC1 signaling also influences cell cycle progression in colonic epithelial cells, and its inhibition can lead to cell cycle arrest.
Transcriptional reprogramming
In simple terms: Genes that promote growth are turned down, and genes that enforce quiescence are turned up.
Transcriptional regulators such as KLF4 and Id-1 modulate the expression of genes involved in proliferation and differentiation. KLF4 represses STAT3-induced proliferation in glomerular epithelial cells, while Id-1 overexpression alters mammary epithelial cell phenotypes, suggesting a role in balancing proliferation and differentiation. Intestine-specific gene transcription also controls epithelial homeostasis.
Differentiation and apoptosis
In simple terms: Cells may stop dividing permanently and become specialized or undergo programmed cell death.
Negative regulation often couples proliferation arrest with differentiation or apoptosis. In tracheobronchial epithelial cells, positive and negative regulation of proliferation and differentiation are tightly linked. Progesterone-dependent modulation of luminal epithelial transcription supports pregnancy in cattle, illustrating hormonal control of epithelial differentiation.
Tissue-level homeostasis
In simple terms: The balance of cell division and cell death keeps the tissue healthy.
At the tissue level, negative regulation ensures that epithelial cell numbers remain constant. mTORC1 regulation of colonic epithelial cell homeostasis is essential; its dysregulation leads to hyperplasia. Fibrotic maladaptive repair is prevented by circBNC2-mediated inhibition of G2-M arrest.
Key Genes Involved in GO:0050680 negative regulation of epithelial cell proliferation
The following genes and proteins are experimentally validated regulators of negative regulation of epithelial cell proliferation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KLF4 | Negative regulator of STAT3-induced glomerular epithelial cell proliferation | Studied in glomerular disease and epithelial homeostasis |
| PTPN2 | Protein tyrosine phosphatase that dampens proliferative signaling | Tumor suppressor in epithelial carcinogenesis |
| ID1 | Helix-loop-helix protein regulating mammary epithelial phenotypes | Involved in balancing proliferation and differentiation |
| MTOR | Kinase in mTORC1 complex controlling colonic epithelial homeostasis | Dysregulation causes hyperplasia |
| STAT3 | Transcription factor promoting epithelial proliferation | Target of KLF4-mediated negative regulation |
| CDKN1A | Cyclin-dependent kinase inhibitor p21, mediates cell cycle arrest | Downstream effector of negative regulation |
| CDKN1B | Cyclin-dependent kinase inhibitor p27, enforces quiescence | Cell cycle brake in epithelial cells |
| TP53 | Tumor suppressor inducing cell cycle arrest and apoptosis | Frequently mutated in epithelial cancers |
| TGFB1 | Cytokine that inhibits epithelial proliferation | Key negative regulator in homeostasis |
| SMAD3 | Transcription factor mediating TGF-beta growth inhibition | Downstream of TGF-beta signaling |
| FOXO3 | Transcription factor promoting cell cycle arrest | Integrates stress signals to limit proliferation |
| PTEN | Lipid phosphatase antagonizing PI3K/AKT growth signaling | Tumor suppressor in epithelial cancers |
| RB1 | Retinoblastoma protein, gatekeeper of G1-S transition | Loss leads to uncontrolled proliferation |
| CDH1 | E-cadherin, mediates contact inhibition | Loss promotes proliferation and invasion |
| GATA6 | Transcription factor regulating epithelial differentiation | Involved in intestine-specific gene transcription |
| HNF4A | Nuclear receptor controlling epithelial gene expression | Regulates intestinal epithelial homeostasis |
| ELF3 | Ets transcription factor with context-dependent roles | Modulates epithelial proliferation |
How Is negative regulation of epithelial cell proliferation Regulated?
Negative regulation of epithelial cell proliferation is controlled by multiple signaling pathways. mTORC1 is a central regulator of colonic epithelial homeostasis; its inhibition reduces proliferation, while hyperactivation leads to hyperplasia. TGF-beta signaling activates SMAD transcription factors to induce cell cycle inhibitors such as p21 and p27. KLF4 acts as a transcriptional brake on STAT3-induced proliferation in glomerular epithelial cells. PTPN2 dephosphorylates growth factor receptors, attenuating proliferative signals. Hormonal cues, such as progesterone, modulate luminal epithelial transcription to support pregnancy, illustrating systemic control. Additionally, circBNC2 regulates G2-M arrest to prevent fibrotic maladaptive repair.
negative regulation of epithelial cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KLF4 | Glomerular disease | Knockout mouse podocytes |
| PTPN2 | Epithelial carcinogenesis | Conditional knockout in skin epithelium |
| MTOR | Colonic hyperplasia | Intestinal epithelial-specific knockout |
| ID1 | Breast cancer | Overexpression in mammary epithelial cells |
| CIRCBNC2 | Fibrotic maladaptive repair | Knockout in kidney epithelial cells |
Cancer
Loss of negative regulation of epithelial cell proliferation is a hallmark of cancer. PTPN2 acts as a tumor suppressor in epithelial carcinogenesis, and its downregulation leads to hyperproliferation. Mutations in TP53 and PTEN, which normally enforce proliferative brakes, are common in epithelial cancers. KLF4 downregulation is associated with glomerular disease and may contribute to proliferative glomerulopathies.
Fibrosis
Dysregulated epithelial proliferation contributes to fibrotic maladaptive repair. circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrosis; its loss leads to uncontrolled proliferation and fibrotic remodeling. mTORC1 dysregulation in colonic epithelium causes hyperplasia and may predispose to fibrosis.
Glomerular disease
KLF4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation. Reduced KLF4 activity leads to abnormal podocyte proliferation and glomerular disease.
Inflammatory bowel disease
mTORC1 regulation of colonic epithelial cell homeostasis is critical; its dysregulation causes epithelial hyperplasia and may contribute to inflammatory bowel disease.
From negative regulation of epithelial cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does KLF4 negatively regulate STAT3-induced proliferation? | KLF4 knockout glomerular epithelial cells |
| What is the role of PTPN2 in epithelial carcinogenesis? | PTPN2 conditional knockout mouse |
| How does mTORC1 control colonic epithelial homeostasis? | Intestinal epithelial-specific mTOR knockout |
| Does circBNC2 inhibit G2-M arrest in fibrosis? | circBNC2 knockout kidney epithelial cells |
| How does Id-1 affect mammary epithelial phenotypes? | Id-1 overexpression in mammary epithelial cells |
| What is the effect of progesterone on luminal epithelial transcription? | Progesterone-treated bovine luminal epithelial cells |
How to Study the negative regulation of epithelial cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Identify genes differentially expressed during proliferation arrest |
| Phosphoproteomics | Phosphorylation events | Quantify signaling changes mediated by KLF4 or PTPN2 |
| EdU incorporation | DNA synthesis | Measure proliferation rate in epithelial cells |
| Flow cytometry | Cell cycle distribution | Detect G2-M arrest |
| Immunofluorescence | Protein localization and expression | Visualize KLF4 or STAT3 in tissue sections |
| CRISPR knockout | Gene function | Test causal role of candidate negative regulators |
| Western blot | Protein expression and phosphorylation | Validate signaling changes |
Transcriptomics
RNA-seq can identify transcriptional changes in epithelial cells upon induction of negative regulation. For example, progesterone-dependent modulation of luminal epithelial transcription was studied using RNA-seq in cattle. Intestine-specific gene transcription has been dissected using transcriptomic approaches.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify changes in signaling pathways, such as STAT3 phosphorylation regulated by KLF4 or tyrosine phosphorylation controlled by PTPN2.
Imaging and proliferation assays
Immunofluorescence for Ki-67 or EdU incorporation measures proliferation rates. Cell cycle analysis by flow cytometry can detect G2-M arrest, as shown for circBNC2.
Functional genomics
CRISPR screens can identify novel negative regulators of epithelial proliferation. For example, genome-wide screens in epithelial cells can uncover genes whose knockout increases proliferation.
How CRISPR Can Be Used to Study GO:0050680 negative regulation of epithelial cell proliferation
Knockout
CRISPR knockout of candidate negative regulators such as KLF4 or PTPN2 can test whether loss of function leads to increased epithelial proliferation. For example, KLF4 knockout in glomerular epithelial cells results in enhanced STAT3-induced proliferation. PTPN2 knockout promotes epithelial carcinogenesis.
Point Mutation
Point mutations can mimic disease-associated variants or abolish catalytic activity. For instance, mutating the phosphatase domain of PTPN2 can reveal its role in dephosphorylating specific substrates. Similarly, point mutations in KLF4 DNA-binding domain can disrupt its repressive function.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-KLF4) allows live-cell imaging and chromatin immunoprecipitation to study dynamics of negative regulation. Knock-in of disease-relevant mutations can model human conditions.
Overexpression
Overexpression of negative regulators such as Id-1 or circBNC2 can suppress proliferation. For example, circBNC2 overexpression inhibits G2-M arrest and prevents fibrotic repair. Id-1 overexpression alters mammary epithelial phenotypes.
How EDITGENE Supports negative regulation of epithelial cell proliferation Research
Researchers studying negative regulation of epithelial cell proliferation-related genes often need to determine whether a candidate gene is causally involved in restricting epithelial growth. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from knockout to overexpression models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of epithelial cell proliferation research.
Frequently Asked Questions About negative regulation of epithelial cell proliferation
What is GO:0050680?
GO:0050680 is the Gene Ontology term for negative regulation of epithelial cell proliferation, describing any process that stops, prevents, or reduces the rate or extent of epithelial cell proliferation.
What genes are involved in negative regulation of epithelial cell proliferation?
Key genes include KLF4, PTPN2, ID1, MTOR, STAT3, CDKN1A, CDKN1B, TP53, and PTEN, among others.
How is negative regulation of epithelial cell proliferation studied?
Researchers use RNA-seq, proteomics, imaging, proliferation assays, and CRISPR knockout/overexpression models.
Why is negative regulation of epithelial cell proliferation important?
It prevents uncontrolled cell growth, maintains tissue homeostasis, and its dysregulation leads to cancer, fibrosis, and other diseases.
What diseases are associated with defects in negative regulation of epithelial cell proliferation?
Cancer, fibrosis, glomerular disease, and inflammatory bowel disease are associated with defects in this process.
What is the role of KLF4 in epithelial cell proliferation?
KLF4 acts as a negative regulator of STAT3-induced glomerular epithelial cell proliferation, and its loss leads to abnormal proliferation.
How does mTORC1 regulate colonic epithelial homeostasis?
mTORC1 controls colonic epithelial cell proliferation and homeostasis; its dysregulation causes hyperplasia.
What is the role of PTPN2 in epithelial carcinogenesis?
PTPN2 acts as a tumor suppressor by dephosphorylating growth factor receptors and dampening proliferative signals.
Can CRISPR be used to study negative regulation of epithelial cell proliferation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process.
What are the synonyms for GO:0050680?
Synonyms include down regulation of epithelial cell proliferation, down-regulation of epithelial cell proliferation, downregulation of epithelial cell proliferation, and inhibition of epithelial cell proliferation.
Conclusion
Negative regulation of epithelial cell proliferation (GO:0050680) is a fundamental biological process that safeguards tissue homeostasis and prevents pathological overgrowth. Dysregulation of this process underlies numerous diseases, including cancer and fibrosis. By leveraging CRISPR-based models and multi-omics approaches, researchers can uncover novel regulators and therapeutic targets. EDITGENE provides end-to-end services to accelerate these discoveries.
References
- 1. Estrada CC et al.. 2018. Krüppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation.. JCI Insight 3(12) PMID: 29925693
- 2. Jetten AM et al.. 1990. Positive and negative regulation of proliferation and differentiation in tracheobronchial epithelial cells.. Am Rev Respir Dis 142(6 Pt 2):S36-9 PMID: 2252274
- 3. Kotani T et al.. 2020. Regulation of colonic epithelial cell homeostasis by mTORC1.. Sci Rep 10(1):13810 PMID: 32796887
- 4. Martins T et al.. 2022. Progesterone-dependent and progesterone-independent modulation of luminal epithelial transcription to support pregnancy in cattle.. Physiol Genomics 54(2):71-85 PMID: 34890509
- 5. Traber PG et al.. 1996. Intestine-specific gene transcription.. Annu Rev Physiol 58:275-97 PMID: 8815796
- 6. Wang P et al.. 2022. Circular RNA circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair.. Nat Commun 13(1):6502 PMID: 36316334
- 7. Morales LD et al.. 2019. The role of T-cell protein tyrosine phosphatase in epithelial carcinogenesis.. Mol Carcinog 58(9):1640-1647 PMID: 31264291
- 8. Lin CQ et al.. 1999. Regulation of mammary epithelial cell phenotypes by the helix-loop-helix protein, Id-1.. Endocr Relat Cancer 6(1):49-50 PMID: 10732787
